Capstone Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Capstone Asset Management's EW Position: Q2 2017 in Review
Capstone Asset Management reduced its Edwards Lifesciences (EW) stake by 3.6% in Q2 2017, selling an estimated $96.4K and leaving 70,221 shares worth $2.77M. The position accounts for 0.08% of the portfolio, ranked #309.
Capstone Asset Management first reported a position in EW in Q2 2013 and has held it in 17 quarters since. The position peaked at $3.22M in Q3 2016. 720 funds tracked by Wall St. Rank hold EW as of Q2 2017.
- Capstone Asset Management held 70,221 shares of Edwards Lifesciences worth $2.77M as of Q2 2017.
- Capstone Asset Management sold 2,640 Edwards Lifesciences shares in Q2 2017, an estimated $96.4K.
- Edwards Lifesciences made up 0.08% of Capstone Asset Management's portfolio in Q2 2017, its #309 holding.
- Capstone Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 17 quarters since.
- Capstone Asset Management's Edwards Lifesciences position peaked at $3.22M in Q3 2016.
- 720 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2017.
Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.